GP Induction Chemotherapy us TPF Adjuvant Chemotherapy Combined With DDP Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC
NCT03604965 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 204
Last updated 2018-07-30
Summary
Through randomized controlled phase III multicenter clinical trials, GP induction chemotherapy vs TPF regimen adjuvant chemotherapy combined with DDP concurrent chemoradiotherapy for the treatment of locally advanced nasopharyngeal carcinoma: the efficacy, toxicity and quality of life, and further improvement Survival rate and improve the quality of life.
Conditions
- Locally Advanced Nasopharyngeal Carcinoma
Interventions
- DRUG
-
GP+CCRT
Patients receive Neoadjuvant gemcitabine (1000mg/m2 on day1 and day8 ) and cisplatin (80mg/m2 on day1)every 21days for three cycles followed by concurrent cisplatin (100mg/m2 on day1 or day2)every 21 days for three cycles during radiotherapy
- DRUG
-
TPF+CCRT
Patients receive Neoadjuvant Docetaxel (75mg/m2 on day1 03:30-04:30) and cisplatin (75mg/m2 on day 1-5 10:00-22:00) and 5-FU(750mg/m2 on day 1-5 22:00-10:00) every 21days for three cycles followed by concurrent cisplatin (100mg/m2 on day1 or day2)every 21 days for three cycles during radiotherapy
Sponsors & Collaborators
-
Guiyang Medical University
lead OTHER
Principal Investigators
-
Yuanyuan Li, Master · Guizhou Provincial Cancer Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 69 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-07-21
- Primary Completion
- 2020-07-21
- Completion
- 2020-07-21
Countries
- China
Study Locations
More Related Trials
-
Induction Chemotherapy Plus Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
NCT04414566 ·Status: UNKNOWN ·Phase: PHASE3
-
Induction Chemotherapy and Immunotherapy Combined Radiotherapy With or Without Concurrent Chemotherapy for Stage III-IVa NPC
NCT06095167 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
GP-induced Chemotherapy Combined With IMRT and TPF-induced Chemotherapy Combined With IMRT in the Treatment of Distant Metastatic Nasopharyngeal Carcinoma
NCT03723343 ·Status: UNKNOWN
-
Neoadjuvant Therapy of GP Chemotherapy Combined With Tislelizumab in Locoregionally Advanced NPC
NCT04833257 ·Status: COMPLETED ·Phase: PHASE2
-
Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
NCT01872962 ·Status: UNKNOWN ·Phase: PHASE3
-
TPC vs PF as Induction Chemotherapy Combined With CCRT for Stage IVa-b Nasopharyngeal Carcinoma
NCT02940925 ·Status: COMPLETED ·Phase: PHASE3
-
GP VS TP in the Treatment of Advanced Nasopharyngeal Carcinoma in Northwest China
NCT01596868 ·Status: COMPLETED ·Phase: PHASE2
-
Phase III Trial of Concurrent Chemotherapy Alone in Patients With Low-risk Nasopharyngeal Carcinoma
NCT05979961 ·Status: RECRUITING ·Phase: PHASE3
-
Adjuvant Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
NCT00677118 ·Status: UNKNOWN ·Phase: PHASE3
-
Nab-TPC vs GP Combined With Camrelizumab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma
NCT06669611 ·Status: RECRUITING ·Phase: PHASE3
-
Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal Carcinoma
NCT04136886 ·Status: RECRUITING ·Phase: PHASE3
-
Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPC
NCT03366415 ·Status: UNKNOWN ·Phase: PHASE3
-
ICCRT vs. CRT for Locally Advanced Nasopharyngeal Carcinoma
NCT05062005 ·Status: RECRUITING ·Phase: PHASE3
-
Toripalimab Vs. Placebo Wtih GP Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
NCT06712888 ·Status: RECRUITING ·Phase: PHASE3
-
A Multicenter Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal Carcinoma
NCT00201396 ·Status: COMPLETED ·Phase: PHASE3
-
Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
NCT01245959 ·Status: UNKNOWN ·Phase: PHASE3
-
Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma
NCT03015727 ·Status: UNKNOWN ·Phase: PHASE3
-
By Comparing TPF Induction Chemotherapy Combined With Nimotuzumab Concurrent Radiotherapy and Cisplatin Concurrent Radio-chemotherapy for Locally Advanced NPC
NCT03557112 ·Status: UNKNOWN ·Phase: PHASE2
-
Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
NCT02434614 ·Status: UNKNOWN ·Phase: PHASE3
-
Prognostic Analysis of Concurrent Chemoradiotherapy With/Without Adjuvant Chemotherapy for Locally Advanced NPC Patients
NCT02973386 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicenter Trial Comparing Multi-course Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
NCT00705627 ·Status: UNKNOWN ·Phase: PHASE3
-
A Multicenter, Prospective, Phase III Randomized Controlled Clinical Study for the Treatment of N2-3 Nasopharyngeal Carcinoma Patients
NCT04061278 ·Status: UNKNOWN ·Phase: PHASE3
-
Cisplatin-based and Carboplatin-based Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma
NCT03919552 ·Status: RECRUITING ·Phase: PHASE3
-
Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
NCT03020329 ·Status: UNKNOWN ·Phase: PHASE2
-
Two Cycles VS Three Cycles Induction Chemotherapy in T1-4N2-3 Locally Advanced Nasopharyngeal Carcinoma
NCT05860868 ·Status: RECRUITING ·Phase: PHASE3